Recherche
-
Comparison of endothelial promoter efficiency and specificity in mice reveals a subset of Pdgfb-positive hematopoietic cells.
(Journal of Thrombosis and Haemostasis. vol. 17, n° 5, pp. 827-840, 2019-01-01)Article de revueLibre accès -
HemosIL VWF:GPIbR Assay Has a Greater Sensitivity than VWF:RCo Technique to Detect Acquired von Willebrand Syndrome in Myeloproliferative Neoplasms.
(Thrombosis and Haemostasis, 2022-06-28)Article de revue -
Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms.
(Leukemia. vol. 35, n° 4, pp. 935-955, 2021-01-01)Article de revue -
HemosIL VWF:GPIbR assay has a greater sensitivity than VWF:RCo technique to detect acquired von Willebrand syndrome in myeloproliferative neoplasms.
(Thrombosis and Haemostasis, 2022-03-23)Article de revue -
Rôle des cellules endothéliales avec mutation JAK2V617F et des polynucléaires neutrophiles dans la physiopathologie de la thrombose des néoplasies myéloprolifératives
(Bordeaux, 2018-11-20)Thèses de doctorat -
Platelets and neutrophils cooperate to induce increased neutrophil extracellular trap formation in JAK2V617F myeloproliferative neoplasms.
(Journal of Thrombosis and Haemostasis, 2023-09-09)Article de revue -
Platelet function studies in myeloproliferative neoplasms patients with Calreticulin or JAK2V617F mutation
(Research and Practice in Thrombosis and Haemostasis. vol. Vol. 7, n° Issue 2, pp. 100060, 2023-02)Article de revueLibre accès -
Assessment of circulating blood lymphocytes in adult patients on rituximab to treat immune thrombocytopenia: Circulating number of NK cells is associated with the response at 6 months.
(British Journal of Haematology, 2023-04-20)Article de revueLibre accès -
Acquired haemophilia A in paediatric patients: A retrospective French cohort of eight cases.
(British Journal of Haematology. vol. 204, n° 2, pp. 606-611, 2024-02-01)Article de revueLibre accès -
Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifs.
(Haematologica, 2024-02-08)Article de revueLibre accès